Povidone-Iodine Antiviral Nasal Spray By Cipla: COVID-19
Naselin by Cipla Health has launched a novel Naselin antiviral nasal spray with povidone-iodine. This spray is intended to protect against COVID-19 and respiratory tract infections. According to research, povidone-iodine can act as the first line of protection against the COVID-19. The spray, which has potent antiviral properties, is apt for widespread use, particularly by the high-risk category of essential service workers.
Povidone-iodine is an approved molecule with antiviral, antibacterial, and anti-fungal properties that help protect against viruses and other microbes that cause upper respiratory tract illnesses such as colds, sinusitis, and flu. Povidone-iodine has been broadly used in products like gargle solutions, ointments, and creams over the years. However, Cipla Health’s use of it in a nasal spray form is a ground-breaking innovation to assure potential protection at the grass-root phases of infection.
It was also claimed that the spray kills the disease-causing viruses and bacteria in the nostrils. Coronavirus invades the body through the nostrils, according to numerous studies. Preventive care requires the usage of topical antiviral medicines in the nasal region. Povidone-iodine, in the convenient packaging of Naselin antiviral nasal spray, provides a simple and effective method of COVID-19 protection
.With normalcy being restored, health officials are highlighting the significance of following all safety protocols. This has increased demand for relevant healthcare products, including nasal care. To meet this requirement, Cipla Health’s Naselin antiviral nasal spray is formulated as daily aid.
The antiviral spray Naselin assures its applicability beyond the current COVID-19 context to any other respiratory tract distress. The 15ml spray bottle costs Rs 99 and is available at 700 Apollo and Medplus pharmacies across Andhra Pradesh, Maharashtra, Telangana, and online platforms like 1mg and Pharmeasy.
Shivam Puri, the CEO, Cipla Health, stated that at Cipla Health, they have always strived to bring products that can make healthcare simple and economical. With a strong commitment to R&D, their products have shown efficacy against a variety of health conditions, allowing people to recover more quickly. Keeping with this pledge, they are pleased to offer the public one of the most innovative and efficient product formulations for COVID-19 prevention. Including Naselin antiviral nasal spray in the daily routine, along with adhering to the protocols given by the government, can undoubtedly help in fighting this pandemic.
Also Read:
- Ph.D. Mandatory From 2023 For Assistant Professors: UGC
- BD-Life Sciences-Biosciences Launches 2nd CoE In Flow Cytometry For Clinical Research
- India To develop Container-based Mobile Hospitals As Part Of PMABHIM
- Two Years Drop In India’s Life Expectancy in 2020 Due To Covid-19
- Predicting Next Virus Spread From Animals to Humans With AI?
- New Secretary of DBT: IISER Professor Rajesh Gokhale
Check out Biotecnika App for more recent Updates, News, and Job vacancies.
